indolebutyric acid has been researched along with meropenem in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsen, TJ; Christopeit, T; Helland, R; Leiros, HK | 1 |
| Christopeit, T; Leiros, HK | 1 |
| Bayer, A; Christopeit, T; Guttormsen, Y; Leiros, HK; Lund, BA | 1 |
3 other study(ies) available for indolebutyric acid and meropenem
| Article | Year |
|---|---|
Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Crystallography, X-Ray; Drug Design; Drug Resistance, Bacterial; Humans; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Small Molecule Libraries; Surface Plasmon Resonance | 2015 |
Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Dose-Response Relationship, Drug; Drug Discovery; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance | 2016 |
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance | 2016 |